- Ağrı Tıp Fakültesi Dergisi
- Vol: 1 Issue: 2
- Examination of Patients Using Paliperidone Palmitate 3-Month Formulation
Examination of Patients Using Paliperidone Palmitate 3-Month Formulation
Authors : Mehmet Hamdi Örüm
Pages : 68-70
View : 25 | Download : 35
Publication Date : 2023-06-22
Article Type : Research Article
Abstract :Adherence problems to oral antipsychotics are common in patients with psychotic disorders. The use of long-acting injectable antipsychotics has been suggested to support adherence management. This study aimed to examine the patients who used paliperidone palmitate 3-month formulation (PP3M). Twenty-one patients (8 females and 13 males) were included in the study. The mean age was 40.90±10.98 years, the age of disorder onset was 18.47±3.64 years, the duration of paliperidone palmitate once-monthly formulation use was 12.38±14.68 months, the duration of PP3M use was 4.66±1.85 months. While 20 patients were diagnosed with schizophrenia, 1 male patient was diagnosed with schizoaffective disorder. Since PP3M does not require long-term continuous drug use and follow-up, its use in patients with adherence problems provides significant benefits.Keywords : Paliperidone palmitate three-month long-acting injection, patient compliance, schizophrenia, schizoaffective disorder